VectivBio Holding AG
VectivBio Holding AG (VECT) Revenue
Annual & quarterly revenue history · segment & region breakdown
VECT · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsVectivBio Holding AG trailing twelve-month (TTM) revenue is $0.03B, an increase of 0.00% year-over-year from $0.03B in FY2022.
Revenue trend
2022 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.03B | +$0.03B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare VECT revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income VectivBio Holding AG receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
VectivBio Holding AG reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from VectivBio Holding AG's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
VECT revenue · 4 questionsVECT's trailing twelve-month (TTM) revenue is $0.03B. That is an increase of 0.00% year-over-year from $0.03B in FY2022.
▸ Source: FMP · VectivBio Holding AG SEC filings · GAAP · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026